Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer

NCT01013129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 748

Last updated 2021-11-11

No results posted yet for this study

Summary

RATIONALE: Gathering information about genetic and environmental factors may help doctors learn more about a person's risk for developing prostate cancer.

PURPOSE: This research project is studying genes, environment, and prostate cancer risk in patients with or without prostate cancer.

Conditions

Interventions

GENETIC

DNA analysis

saliva samples will be collected from men (probands) who join the study.

GENETIC

polymorphism analysis

we will genotype DNA samples (buccal) from all probands and conduct a traditional case-control analysis

OTHER

laboratory biomarker analysis

10ml blood specimen will be obtained and processed (on probands locally-consented and/or those who have an appointment at the VA in Portland, Oregon) to allow for analyses of erythrocyte fatty acids and future nutrient and DNA analyses

OTHER

medical chart review

PSA results, prostate biopsy pathology reports and clinician notes related to the biopsy are reviewed for final data analysis

OTHER

questionnaire administration

probands are asked to complete questionnaires on 1) family history of cancer, 2) diet history over the past year, 3) employment environment and risk factors and/or 4) changes to diet, medications since enrollment in originating case control study

PROCEDURE

evaluation of cancer risk factors

pathology reports will be reviewed for probands whose prostate biopsies reveal cancer; these factors will be evaluated for cancer risk factors

PROCEDURE

study of high risk factors

prostate biopsy pathology reports will be reviewed for high risk factors

Sponsors & Collaborators

  • Portland VA Medical Center

    lead FED

Principal Investigators

  • Jackilen Shannon, PhD · Portland VA Medical Center

Eligibility

Min Age
21 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01013129 on ClinicalTrials.gov